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Recently, we established keratin 10-deficient mice,
serving as a model for the hyperkeratotic skin
disorder epidermolytic hyperkeratosis. The consider-
able ichthyosis in these mice suggested alterations in
terminal differentiation and in the formation of a
functional epidermal barrier. Here, we report on the
ultrastructural organization and composition of the
stratum corneum lipids and on the expression of two
major cornified envelope proteins. Electron micro-
scopy of ruthenium tetroxide postfixed skin samples
demonstrated a normal extrusion and morphology of
lamellar bodies as well as the formation of bona fide
lamellar layers in neonatal keratin 10-deficient mice.
When we studied the composition of the major
stratum corneum lipids, however, we found significant
changes. Most importantly, the analysis of ceramide
The most important function of the epidermis is theformation and maintenance of a barrier that protectsthe organism against environmental damage and fromdesiccation. This barrier is located in the stratumcorneum (SC) and consists of at least two components:
the proteinaceous, highly cross-linked cornified envelope (CE) and
the extracellular lipid lamellae (Elias and Menon, 1991). An
important issue is to understand whether the intracellularly located
keratin (K) cytoskeleton plays a part in the three-dimensional
organization of extracellular lipids.
Keratins are the major proteins of the epidermis and represent
70% of the dry weight of the SC. In the suprabasal epidermis,
intermediate filaments consisting of K1/K10 (Moll et al, 1982),
supplemented by K2e and K9 in certain subsets of keratinocytes
(Rentrop et al, 1987; Langbein et al, 1993), are the most prominent
ones. The recent discovery of inherited skin disorders due to point
mutations in keratin genes (Corden and McLean, 1996) and the
analysis of transgenic and knockout mice (Fuchs and Weber, 1994;
Manuscript received February 1, 1999; revised June 3, 1999; accepted
for publication June 3, 1999.
Reprint requests to: Dr. Thomas M. Magin, Institut fu¨r Genetik, Abt.
Molekulargenetik, Ro¨merstr. 164, 53117 Bonn, Germany.
E-mail: t.magin@uni-bonn.de
Abbreviations: CE, cornified envelope; EH, epidermolytic hyper-
keratosis; LB, lamellar body; SC, stratum corneum; SG, stratum granulosum.
0022-202X/99/$14.00 · Copyright © 1999 by The Society for Investigative Dermatology, Inc.
329
subpopulations revealed that the total amount of
ceramide 2 was elevated in keratin 10-deficient
mice, whereas ceramides 1, 3, 4, and 5 were
decreased among total stratum corneum lipids. The
amount of the ceramide precursors sphingomyelin
and glucosylceramide was reduced in the stratum
corneum without accompanying changes in the
mRNA coding for acid sphingomyelinase. Notably,
we found an increased mRNA and protein content
for involucrin in neonatal keratin 10-deficient mice,
whereas the expression of loricrin was not changed.
Our data demonstrate that, although the formation
of lipid layers in the stratum corneum appeared to
be normal, its lipid composition is significantly
altered in keratin 10-deficient mice. Key words: ceramide/
involucrin/keratin 10/lamellar body. J Invest Dermatol
113:329–334, 1999
Magin, 1998) have clearly demonstrated that the provision of a
cytoskeleton is an indispensable function of keratin intermediate
filaments. Whereas cross-links between K10 or K1 and proteins of
the CE have been identified (Ming et al, 1994; Steinert and
Marekov, 1995, 1997; Candi et al, 1998), it remains to be shown
whether they play an active part in the ordered formation of the CE.
The CE is composed of several proteins. According to a recent
model, involucrin is an important scaffold protein to which
numerous additional proteins are cross-linked by transglutaminases,
probably in a defined and sequential manner (Steinert and Marekov,
1997; Nemes et al, 1999). Among those are small proline-rich
proteins, elafin, filaggrin, loricrin as well as plakins (Steinert and
Marekov, 1995, 1997; Candi et al, 1998, 1999; Marekov and
Steinert, 1998). Interestingly, loricrin, which is covalently bound
to numerous CE proteins via transglutaminase-induced cross-links,
is additionally cross-linked to filaggrin, K1, and K10 (Steinert and
Marekov, 1995). In corneocytes, keratin bundles are oriented
parallel to the surface of the CE.
Corneocytes are embedded in a lipid matrix consisting mainly
of ceramides, free fatty acids, and cholesterol. These lipids and their
precursors are extruded from keratinocytes in the upper granular
layer via lamellar bodies (LB), which also contain numerous
hydrolytic enzymes, including sphingomyelinase (Freinkel and
Traczyk, 1985; Grayson et al, 1985). After being secreted, the
extruded lipids build highly ordered multilamellar layers which
constitute a major part of the epidermal water permeability barrier
(Landmann, 1986; Elias and Menon, 1991). Interestingly, the
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number, morphology, and secretion of LB has been found to be
reduced in several disorders of cornification (Fartasch, 1997). An
increase in transepidermal water loss has been detected in lamellar
ichthyosis (Huber et al, 1995), X-linked recessive ichthyosis
(Williams, 1991), Vohwinkels syndrome (Maestrini et al, 1996), and
epidermolytic hyperkeratosis (EH; Frost et al, 1968). EH is due to
point mutations in highly conserved sequences of K1 or its partner
K10 (Cheng et al, 1992; Rothnagel et al, 1992; Chipev et al, 1994).
We previously established K10-deficient mice which turned out
to represent a good model for EH (Porter et al, 1996). Most
importantly, homozygous neonatal K10-deficient mice exhibited
an extremely delicate epidermis and died a few hours after birth.
Heterozygous littermates showed a normal skin at birth but
developed increasing hyperkeratosis as they grew up.
Here, we present the analysis of the major lipid and protein
constituents of the SC in neonatal K10-deficient mice. Furthermore,
we investigated the extrusion and transformation of LB contents
by electron microscopy in these animals.
MATERIALS AND METHODS
Electron microscopy Biopsies were taken from fetal (E19) and neonatal
mice and minced to , 0.5 mm3. They were fixed for 4 h in cacodylate-
buffered 2.5% glutaraldehyde. Half of the samples were postfixed with 1%
aqueous osmium tetroxide (OsO4), containing 1.5% potassium ferrocyanide
and the other half with 0.5% ruthenium tetroxide (RuO4, Polysciences,
Warrington, PA)/0.25% aqueous potassium ferrocyanide at pH 6.2 for 1 h
in the darkness at 5°C (Fartasch et al, 1993; Fartasch and Ponec, 1994).
After rinsing in buffer for 3 h and dehydration in graded ethanol series,
the OsO4-fixed samples were embedded in Glycidether 100 (Sigma,
Deisenhofen) and the RuO4-fixed samples were embedded in low
viscosity Epon (Electron Microscopic Science, Fort Washington, PA). Thin
sections were examined before and after double-staining with ethanolic
uranyl acetate and lead citrate with a Jeol 100 CX electron microscope.
Serial semithin sections of OsO4-fixed samples were stained with 1%
methylene blue.
SC preparation and lipid analysis Neonatal mice were killed and total
trunk skin was dissected immediately. The skin was spread upside down
on a precooled (–20°C) glass Petri dish. Subcutaneous tissue was removed
by gentle scraping with a scalpel. The remaining skin was floated on 0.5%
trypsin/phosphate-buffered saline for 30 min at 37°C in a plastic Petri
dish, followed by sonication for 10 min and three washes with phosphate-
buffered saline. Subsequently, the SC was separated from the epidermis
with forceps. The individual SC preparations were homogenized,
lyophilized, and weighed. Lipids were extracted in chloroform–methanol–
water (1:2:0.6, vol/vol/vol) for 24 h at 37°C. For separation of ceramides
total lipid extracts were applied to thin-layer silica gel 60 plates (Merck,
Darmstadt, Germany), and the chromatograms were developed twice with
chloroform–methanol–acetic acid (190:9:1, vol/vol/vol).
Fatty acids were separated according to Ponec et al (1988). After
application of total lipid extracts to high-performance thin-layer chromato-
graphy plates (Merck, Darmstadt, Germany) the chromatograms were
developed using chloroform–methanol (9:1, vol/vol) (up to 10 mm) as the
first and chloroform–diethylether–ethyl acetate (80:4:16, vol/vol/vol) (up
to 90 mm) as the second solvent system.
For quantitation of cholesterol, glucosylceramide, and sphingomyelin,
residual phospholipids were degraded by alkaline hydrolysis with 2 ml
methanolic sodium hydroxide (50 mM) for 2 h at 37°C. After neutralization
with acetic acid, lipid extracts were desalted by reversed-phase chromato-
graphy on LiChroprep RP18. Neutral and anionic lipids were separated by
anion-exchange chromatography on DEAE-Sepharose CL6B (Pharmacia
Freiburg, Germany) and applied to thin-layer silica gel 60 plates. The
chromatograms were developed using chloroform–methanol–aqueous
CaCl2 (0.22%) (60:35:8, vol/vol/vol) for separation of glucosylceramide
and sphingomyelin and using chloroform–methanol–acetic acid (190:9:1,
vol/vol/vol) for separation of cholesterol.
For quantitative analytical thin-layer chromatography determination,
increasing amounts of standard lipids N-stearoyl-sphingosine (kind gift
from Beiersdorf, Germany), cholesterol, palmitic acid and sphingomyelin
(all from Sigma Deisenhofen, Germany) and glucosylceramide (purified
from Gaucher spleen, Sandhoff lab) were applied. After development,
plates were air-dried, sprayed with 8% (wt/vol) H3PO4 containing 10%
(wt/vol) CuSO4, charred at 180°C for 10 min and quantitated by
photodensitometry (Shimadzu Kyoto, Japan).
Statistical evaluation of data was performed using a two-tailed Student’s
t test.
Sodium dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis
and western blot Total protein was extracted from neonatal skin in
SDS–polyacrylamide gel electrophoresis sample buffer (50 mM sodium
phosphate, pH 6.8, 5% SDS, 40 mM dithiothreitol, 5 mM ethylenediamine
tetraacetic acid, 5 mM ethyleneglycol-bis(β-aminoethyl ether)-N,N,N9,N9-
tetraacetic acid and 15% glycerol). The samples were homogenized and
heated for 5 min at 95°C. Insoluble material was removed by centrifuga-
tion. Total protein was determined by the BioRad protein quantitation kit
and extracts were loaded equally. Separation of total protein extracts
was carried out by standard procedures (10% SDS–polyacrylamide gel
electrophoresis). Proteins were electrotransferred to polyvinylidene difluor-
ide membranes (Millipore, Eschborn, Germany) by wet blotting with
20 mM sodium borate/1 mM ethylenediamine tetraacetic acid, pH 9.2.
Membranes were stained with 0.2% Coomassie/40% methanol/5% acetic
acid and destained with 40% methanol/5% acetic acid. Primary antibodies
(Hiss Diagnostics, Freiburg, Germany) were diluted as follows: loricrin
anti-serum (AF 62, 1:20 000) and involucrin anti-serum (1:30 000).
Immunodetection was performed with horseradish peroxidase-conjugated
antirabbit secondary antibodies (Dianova, Hamburg, Germany, 1:30 000)
using Super Signal (Pierce, St. Augustin, Germany) as a substrate.
Indirect immunofluorescence Sectioning and immunofluorescence
analysis of the skin samples was performed as previously described (Reichelt
et al, 1997). Primary antibodies (Hiss Diagnostics, Freiburg) were diluted
1:500 (AF 62, loricrin anti-serum) and 1:200 (involucrin anti-serum).
The secondary antibody, Cy3-conjugated goat anti-rabbit IgG (Dianova,
Hamburg, Germany), was diluted 1:800.
RNA preparation and northern blot Trunk skin of neonatal mice
was prepared immediately after decapitation and either frozen in liquid
nitrogen or directly used for RNA extraction according to Chomczynski
and Sacchi (1987). Thirty micrograms of RNA were loaded per lane on
1% agarose gels (2% agarose gels for Fig 7) in the presence of formamide/
formaldehyde. After separation RNA was transferred onto Genescreen
membrane (NEN, Dreieich, Germany) by capillary transfer using 10 3
SSPE as buffer (Sambrook et al, 1989).
Hybridization was performed overnight at 37°C for the acid sphingo-
myelinase probe and at 42°C for the other probes (for detailed conditions,
see Magin et al, 1998). Blots were washed 3 3 with 300 ml of 0.1 3
SSPE/0.1% SDS at 55°C for the acid sphingomyelinase probe and at 65°C
for the other probes. A probe of about 200 bp length for mouse loricrin
was derived from the 39 noncoding region (kind gift of Dennis Roop,
Houston, TX). As a probe for mouse involucrin a 1.3 kb HindIII fragment
derived from a cDNA clone was used (kind gift of Philippe Djian, Meudon-
Bellevue, France). Acid sphingomyelinase was probed with a 1.4 kb
fragment of the 39 human cDNA clone sequence which showed 81%
sequence identity to the mouse sequence. The TRI-GAPDH-Mouse anti-
sense template (Ambion, Frankfurt, Germany) was used as a control.
RESULTS
Ultrastructural alterations of the epidermis of K10-deficient
mice Previous ultrastructural analysis of K10-deficient mice had
been focused on the living layers of the epidermis and investigated
the localization of keratin intermediate filaments and aggregates of
K1/10 in relation to keratohyalin granules (Reichelt et al, 1997).
To examine the ultrastructure of the SC and SG/SC transition
layer, postfixation with osmium tetroxide and ruthenium tetroxide
were used. Whereas osmium staining permitted assessment of
routine ultrastructural features, including LB, ruthenium tetroxide
revealed the organization of SC intercellular lipids.
In neonatal (not shown) and fetal (E19) homozygous K10-
deficient mice intraepidermal bullae resulted from separation of
edematous cells from one another (Fig 1a). Intact SG cells next to
cytolysing cells showed LB with regular morphology which fused
with the upper SG membrane and appeared to secrete their lipid
content (Fig 1b). The epidermis of neonatal homozygous K10-
deficient mice showed 12–15 SC layers whereas the wild type
exhibited only approximately 10 layers. Especially the matrix of the
corneocytes of the lower SC showed electron-dense aggregations of
filament-like structures and an irregular staining pattern. Keratin
clumping was present in bullous as well as in nonbullous areas
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Figure 1. Ultrastructural analysis
revealed normal extrusion of LB in
K10-deficient mice. Homozygous fetal
K10-deficient skin (E19) displayed intra-
epidermal bullae (B) resulting from separa-
tion of cytolytic cells of the upper SG and
spinous layer (a, OsO4 staining, scale bar:
10 µm). Intact SG cells next to cytolytic
areas were still capable of secreting LB
lipids (arrow) at the SG/SC interface (b,
KH: keratohyalin, OsO4 staining, scale bar:
1 µm).The epidermis of neonatal homozy-
gous K10-deficient mice showed cytolytic
disruption of some of the SG and stratum
spinosum cells (c, C). Clumping of keratins
was mostly found in the periphery of the
cells (c, arrows, OsO4 staining, scale bar:
2 µm). In regions where the SG and
stratum spinosum cells lacked cytolytic clear
spaces LB secretion and intercellular forma-
tion of LB sheets at the SG/SC interface
was normal (d, arrows; RuO4-staining; scale
bar: 0.1 µm). Mature lamellar lipid layers
were found in the intercellular spaces of
the horny layer (e, RuO4-staining; scale bar:
0.1 µm).
(Fig 1c). There were variously sized clear spaces around the nuclei
of the upper stratum spinosum and SG cells. Peripheral to the
cytolytic clear spaces (Fig 1c, C), the cells showed thick shells of
irregularly clumped keratin filaments.
The quantity of LB in the cytosol of the SG cells of homozygous
mice varied greatly. In regions with severe cytosolic swelling, LB
were conspicuously reduced. In some areas, where the corneocytes
showed a CE and an intact lipid envelope, LB sheets were present
in the intercellular space of the SG/SC interface (Fig 1d). As in
wild-type epidermis the LB sheets were found in the extracellular
domains of the lower SC, whereas fully processed, mature lamellar
lipid layers were observed in the extracellular domains of the
middle and upper part of the SC (Fig 1e).
In neonatal heterozygous mice, the extrusion of LB contents
and the subsequent transformation of LB-derived membrane sheets
into mature lamellar membrane unit structures with a characteristic
pattern of repeating electron-lucent and electron-dense lamellae
was normal.
Disruption of the keratin cytoskeleton is accompanied by
alterations of the composition of SC lipids The SC lipids in
animal models for EH (Fuchs et al, 1992; Bickenbach et al, 1996;
Takahashi and Coulombe, 1996) have not yet been determined.
After isolating the epidermis of neonatal K10-deficient and wild-
type mice, we investigated the lipid content of SC fractions. We
found an enormous increase in total lipid per mg SC dry weight
in homozygous neonatal K10-deficient mice (89.1 µg) compared
with wild-type littermates (48.3 µg). The value of heterozygous
animals (62.6 µg) was intermediary between the results of
homozygotes and controls. The increase comprised all major SC
lipids, namely cholesterol, free fatty acids, and ceramides (Fig 2a).
The analysis of individual ceramide subpopulations revealed that
the overall increase in ceramides was based on the increase in
ceramide 2 [or NS using the nomenclature of Motta et al (1993)
as revised by Robson et al (1994)] (Fig 2b). In percentage of total
SC lipid, ceramides 1 (EOS), 3 (NP), 4 (AS), and 5 (AS)
were decreased in hetero- and homozygous K10-deficient mice.
Individual ceramides differ from each other according to the
hydroxylation of either sphingoid bases (S 5 sphingosine, p 5
phytosphingosine) or N-acyl fatty acids (N 5 nonhydroxy,
A 5 α-hydroxy, O 5 ω-hydroxy) and whether the ω-position is
further acylated (i.e., esterified 5 E) (Madison et al, 1990; Doering
et al, 1999). The ceramide precursors glucosylceramide and sphingo-
myelin were both reduced in SC preparations (Fig 2c). At present,
it is not possible to decide whether the changes in lipids are due
to the loss of cytoarchitecture in cytolysing cells (Porter et al, 1996),
or whether they result from an altered epidermal differentiation
program as indicated by the expression of K6 and K16 (Reichelt
et al, 1997; Porter et al, 1998).
Selective changes in CE precursor proteins Recently, we
reported a strong increase in keratohyalin in the upper epidermis
of K10-deficient mice which pointed to an altered terminal
differentiation (Reichelt et al, 1997). In order to elucidate whether
other proteins expressed during terminal differentiation were also
altered as found in the human condition (Kanitakis et al, 1987;
Ishida-Yamamoto et al, 1995), we analyzed the expression of
involucrin and loricrin.
By immunofluorescence analysis of frozen sections the distribu-
tion of involucrin showed no significant differences between
K10-deficient mice and wild-type littermates (Fig 4d–f). By western
blotting (Fig 3, lanes 4–6), however, we found an increase in
involucrin which was accompanied by a significantly increased
expression of the corresponding mRNA in neonatal epidermis of
homozygous and to a minor extent also in heterozygous K10-
deficient mice (Fig 5a).
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Figure 2. Altered SC lipid composition in K10-deficient mice.
Levels of the main SC lipids (cholesterol, free fatty acids, and total
ceramides) are shown (a). Separate levels of five individual murine SC
ceramides (b). Note the increased amount of ceramide 2 in homozygous
K10-deficient mice and the mainly unchanged levels of the other
ceramides in relation to SC dry weight. Residual amounts of sphingomyelin
and glucosylceramides in the SC are indicated (c). Each value is the mean
of four different animals 6 SEM. The lipid levels of heterozygous
and homozygous mice differed significantly from wild-type levels at
***p ø 0.001, **p ø 0.005, or *p ø 0.08. n.s., not significant.
In contrast, loricrin was not altered at the protein or mRNA
expression level as shown by western blotting (Fig 3, lanes 1–3),
by immunofluorescence staining (Fig 4a–c) or northern blot analysis
(Fig 5b). Interestingly, we discovered allelic size variants of both
loricrin and involucrin in distinct mouse strains (Figs 3 and 6).
We examined BALB/C, C57Bl/6, and 129/Sv mice and found
that the latter two expressed a 95 kDa involucrin whereas in
BALB/C mice the protein was about 5 kDa smaller. Loricrin was
about 5 kDa larger in BALB/C than the corresponding protein in
C57Bl/6 or 129/Sv. Mice that were derived from a cross between
BALB/C and C57Bl/6 expressed both size variants. These size
variants are also reflected at the mRNA level (Fig 7). At present,
we do not know, however, whether the size difference seen for
both mRNAs is due to coding or noncoding sequences.
DISCUSSION
It is well documented that the SC lipids are important factors in
the formation of a functional epidermal permeability barrier (Elias
Figure 3. Western blotting revealed an increase in involucrin in
K10-deficient mice. Equal amounts of total protein extracts from neonatal
skin were loaded. Lanes 1 and 2 show the expression of loricrin in wild-
type and heterozygous K10-deficient mice, respectively, which resulted
from a BALB/C and C57Bl/6 cross. Note that two allelic size variants were
expressed. Homozygous neonatals on a C57Bl/6 background expressed
exclusively the smaller sized variant (lane 3). The expression of involucrin
in wild-type (lane 4), heterozygous (lane 5) and homozygous (lane 6) K10-
deficient epidermis from C57Bl/6 mice was different among the genotypes.
The amount of involucrin was increased in heterozygous and to an even
greater extent in homozygous K10-deficient mice. Size markers are from
top to bottom: 97 kDa (right), 66 kDa and 56 kDa (left). Equal amounts
of protein were loaded (see Materials and Methods).
Figure 4. Immunofluorescence staining of loricrin and involucrin.
(a–c) Show the expression of loricrin and (d–f) the expression of involucrin
in wild-type (a, d), heterozygous (b, e) and homozygous (c, d) neonatal
K10-deficient epidermis. Loricrin was detected in the granular layer in all
genotypes whereas involucrin was localized in the SC. The basal layer is
outlined by arrowheads, asterisks show areas of cytolysis in the granular layer
of homozygous epidermis. Scale bar: 40 µm.
and Menon, 1991) which is known to be impaired in EH (Frost
et al, 1968). Most importantly, our study has revealed that as a
consequence of disrupting the gene for K10, the composition of
SC lipids became altered. Notably, these changes did not lead to
an impaired processing of LB contents except in cytolytic cells. SC
lipids are concentrated in lamellar bodies where they form lamellar
stacks. These characteristic organelles which also contain numerous
hydrolases increase in number as the keratinocytes differentiate and
are finally actively extruded from terminally differentiating cells. In
contrast to the alterations in LB morphology and secretion that
have been described for several disorders of cornification (Ghadially
et al, 1992; for review see Fartasch, 1997) our electron microscopy
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Figure 5. Northern analysis of epidermal differentiation markers.
Total RNA of trunk skin of neonatal wild-type (lane 1), heterozygous (lane
2) and homozygous (lane 3) K10-deficient mice were hybridized with
probes specific for involucrin (a), loricrin (b), acid sphingomyelinase (c),
and GAPDH (d). Involucrin mRNA was clearly increased in heterozygous
and massively in homozygous skin.
Figure 6. Size variations of involucrin and loricrin in different
mouse strains. Western blots of total protein extracts from neonatal trunk
skin were probed with specific anti-sera. Littermates from a cross between
C57Bl/6 and BALB/C mice expressed both size variants as it is shown for
a wild-type (lane 1) and a heterozygous K10-deficient animal (lane 2). A
homozygous K10-deficient neonate on a C57Bl/6 background expressed
the large variant (lane 3). In BALB/C mice (lane 4) the involucrin-specific
anti-serum detected a band of about 95 kDa whereas C57Bl/6 (lane 5)
and 129/Sv (lane 6) mice showed a protein of 100 kDa whereas BALB/C
mice expressed a larger loricrin (lane 7) than C57Bl/6 (lane 8) or 129/Sv
mice (lane 9) where the protein migrated at about 53 kDa. The size marker
on the left (97 kDa) corresponds to lanes 1–6 and the size markers on the
right (from top to bottom: 66 kDa and 56 kDa) correspond to lanes 7–9.
Equal amounts of protein were loaded (see Materials and Methods).
Figure 7. Northern blot analysis revealed different mRNA sizes for
involucrin and loricrin in different mouse strains. Trunk skin RNA
of neonatal wild-type C57Bl/6 (lanes 1 and 3) and BALB/C (lanes 2 and
4) mice were hybridized with probes specific for involucrin (lanes 1 and
2) and loricrin (lanes 3 and 4). The mRNA for both proteins were about
0.1 kb larger in C57Bl/6 mice than in BALB/C.
analysis of K10-deficient epidermis showed that the number and
extrusion of LB were not markedly altered in homozygous K10-
deficient mice. Also, we found regular lamellar sheets and a normal
lamellar layer structure in the extracellular compartment. These
data demonstrate that hyperkeratosis needs not necessarily be
accompanied by visible alterations in lipid structures of the SC,
although its lipid content and composition may be clearly affected.
We found that levels of ceramides 1, 3, 4, and 5 remained
unchanged in K10-deficient mice whereas the other SC lipids,
including ceramide 2, were increased when compared with wild-
type littermates. These data are in accordance with those demon-
strating a decrease in all ceramide subpopulations as a percentage
of total lipid in EH (Paige et al, 1994). The significant increase in
ceramide 2 in our mice cannot be explained at the moment.
Ceramide 2 is the major epidermal ceramide but it is not restricted
to this tissue like, for example, ceramide 1, which is exclusively
found in the epidermis. Moreover, ceramide synthesis of basal
keratinocytes is limited to ceramide 2 production whereas genera-
tion of the full series of ceramides found in SC is restricted to
differentiated keratinocytes of the stratum spinosum and granulosum
(Madison et al, 1990). Therefore, the observed imbalance in
ceramide composition may result from an altered keratinocyte
differentiation. It will be interesting to analyze further the ratio of
free ceramides to CE-bound ω-hydroxyceramides, the latter of
which are thought to play a part in the organization of the
intercellular lipids and were found in a covalent linkage with
involucrin (Swartzendruber et al, 1987; Marekov and Steinert,
1998).
Despite a seemingly intact ultrastructure of the extracellular
lamellar layer we would predict an increased transepidermal water
loss in K10-deficient mice. An increased transepidermal water loss
might result from the occurrence of large-scale blisters (Porter et al,
1996) as well as from numerous microlesions not visible to the eye
(this study, see Fig 1a).
SC ceramides are predominantly derived from glucosylceramide
and sphingomyelin (Elias et al, 1979; Lampe et al, 1983). Here, we
reported a reduction of both ceramide precursors in SC preparations
of K10-deficient mice. Although the amounts of both precursors
are low in the SC in comparison with SG cells, their decrease in
the SC may reflect a more effective enzymatic processing in K10-
deficient mice. This change did not result from an increase in the
mRNA level of acid sphingomyelinase, an enzyme that is responsible
for the release of ceramides from sphingomyelin. It remains to be
determined whether its activity or subcellular distribution are altered
in K10-deficient mice.
Whereas we observed an increase in total extractable lipids per
mg SC dry weight in the K10-deficient mice, a similar study
performed in samples of EH patients reported no such changes
(Paige et al, 1994). In acute barrier disruption, however, an increase
in lipid synthesis has been observed (Holleran et al, 1991; Harris
et al, 1997). This apparent discrepancy can be resolved by the
following observation: we have previously noted a considerable
decrease in the suprabasal keratins of K10-deficient mice (Porter
et al, 1996). Given that about 70% of the SC dry weight consists
of keratin, it easily follows that the overall change in lipids per mg
SC dry weight could at least in part result from a proportional
decrease in keratin.
Recently, a more than 2-fold elevation of involucrin immuno-
staining was reported in EH patients (Kanitakis et al, 1987; Ishida-
Yamamoto et al, 1995). A similar analysis in K10-deficient mice
did not reveal major alterations of involucrin’s distribution pattern
or staining intensity. Immunofluorescence staining of cryosections
is, however, certainly not a quantitative technique. By western and
northern blotting a significant increase in involucrin in K10-
deficient mice was very obvious, along with a similar increase in
profilaggrin (Reichelt et al, 1997; Reichelt et al, in preparation).
At the same time, the amount of loricrin remained constant. As
we have shown before, the disruption of the intermediate filament
cytoskeleton is accompanied by an increase in K6 and 16 (Reichelt
et al, 1997; Porter et al, 1998) which are considered as markers for
altered keratinocyte differentiation. The fact that we observed an
increase in one CE protein whereas another one was not altered
indicated that the changes were not simply a result of epidermal
disruption but result from selective mechanisms triggered by the
disruption of keratin 10. It will be interesting to investigate how
changes in the keratin cytoskeleton lead to changes in epidermal
lipids and CE proteins.
Finally, we have noted size variants of loricrin and involucrin
in BALB/C and C57Bl/6 mouse strains. Two-dimensional gel
electrophoresis data (not shown) do exclude phosphorylation to
account for the size difference. The presence of differently sized
mRNAs coding for both proteins in the two mouse strains does
favor the existence of allelic variants, perhaps with varying extent
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of glycine repeats. A final answer has to await the cloning and
sequencing of the corresponding cDNA.
We are very grateful to Dr. Philippe Djian and Dr. Dennis Roop for involucrin
and loricrin cDNA clones. Supported by SFB 284 (K.S. and T.M.M.).
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